Hepatitis C virus puts about 130 million people worldwide at risk for severe liver disease, but no vaccine or broadly effective therapy yet exists. A new study identifies receptor tyrosine kinases as host factors required for hepatitis C virus entry—potentially opening the door for new antiviral strategies (pages 589–595).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Scarselli, E. et al. EMBO J. 21, 5017–5025 (2002).
Pileri, P. et al. Science. 282, 938–941 (1998).
Evans, M.J. et al. Nature 446, 801–805 (2007).
Ploss, A. et al. Nature 457, 882–886 (2009).
Lupberger, J. et al. Nat. Med. 17, 589–595 (2011).
Verna, E.C. & Brown, R.S. Jr. Clin. Liver Dis. 12, 637–659 (2008).
Eierhoff, T., Hrincius, E.R., Rescher, U., Ludwig, S. & Ehrhardt, C. PLoS Pathog. 6, e1001099 (2010).
Chung, Y.H. et al. Cancer 89, 977–982 (2000).
Duong, F.H., Christen, V., Lin, S. & Heim, M.H. Hepatology 51, 741–751 (2010).
Vermehren, J. & Sarrazin, C. Clin. Microbiol. Infect. 17, 122–134 (2011).
Guedj, J., Rong, L., Dahari, H. & Perelson, A.S. J. Viral Hepat. 17, 825–833 (2010).
Fofana, I. et al. Gastroenterology 139, 953–964 (2010).
Syder, A.J. et al. J. Hepatol. 54, 48–55 (2011).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
C.M.R. is a member of the Scientific Advisory Board of iTherX, a company with a candidate hepatitis C virus entry inhibitor.
Rights and permissions
About this article
Cite this article
Gerold, G., Rice, C. Locking out hepatitis C. Nat Med 17, 542–544 (2011). https://doi.org/10.1038/nm0511-542
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0511-542
This article is cited by
-
Making the most of the host
Science-Business eXchange (2011)
-
Hepatitis C virus and lipid profiles: more questions than answers?
Hepatology International (2011)